Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-111052

Chief Business Officer sold 11,000 shares at $46.28 ($509,080)

  • Chief Business Officer acquired 11,000 shares (option exercise)
  • Chief Business Officer gave 830 shares (gift)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2024-09-27 Gift 10b5-1 +415 9,665 I
Robb Gary Charles Chief Business Officer 2024-09-27 Gift 10b5-1 +415 9,665 I
Robb Gary Charles Chief Business Officer 2024-10-01 Option exercise 10b5-1 +11,000 $3.29 $36,190 33,772 D
Robb Gary Charles Chief Business Officer 2024-10-01 Sale 10b5-1 −11,000 $46.28 $509,080 22,772 D
Derivatives
Robb Gary Charles Chief Business Officer 2024-10-01 Option exercise · Stock option (right to buy) 10b5-1 −11,000 14,037 D
Open-market sales · 11,000 sh · avg $46.28 · $509,080
Loading xslF345X05/ownership.xml…